Overview

Effects of High Dose Calcitriol in Breast Cancer Patients

Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This research will examine the effectiveness of calcitriol in treating bone loss in women who are about to begin treatment for breast cancer. Twenty-five (25) subjects are expected to take part in this study. The investigators don't know if bone loss in breast cancer survivors should be treated differently than bone loss in other women.
Phase:
Phase 2
Details
Lead Sponsor:
University of Rochester
Treatments:
Calcitriol